AMGN vs LDWY · P/E 24, rev $10.05B vs rev $37.8M
Amgen Inc (AMGN) versus Lendway Inc. (LDWY) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Lendway Inc. (LDWY) is a advertising agencies company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported LDWY revenue for 2024-12-31 was $37.8M. Net income was -$6.7M. Revenue was up 100.9% from 2022-12-31 to 2024-12-31. LDWY currently screens at market cap $9.3M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. LDWY currently screens at market cap $9.3M.
Not investment advice. Open the AMGN and LDWY stock pages for the full models.
Not investment advice.